Houseparty
- WeightWatchers announced Monday it was buying Sequence, a clinical weight management platform.
- Members will get Sequence's services including telehealth visits and prescriptions for weight loss drugs like Ozempic.
- WeightWatchers said it will pay $106 million for the acquisition in a combination of cash and stock.
WeightWatchers announced Monday that it is buying Sequence, a digital health platform for clinical weight loss management, in a $106 million deal.